BBVA USA’s Sanofi SNY Stock Holding History

BBVA USA’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.95M	Buy	40,469 +260	+0.6%	+$13.2K	0.11%	178
2021 Q2	$2.12M	Buy	+40,209	New	+$2.1M	0.12%	170

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

BBVA USA's SNY Position: Q3 2021 in Review

BBVA USA increased its Sanofi (SNY) stake by 0.65% in Q3 2021, buying an estimated $13.2K and bringing the position to 40,469 shares worth $1.95M. The position accounts for 0.11% of the portfolio, ranked #178.

BBVA USA first reported a position in SNY in Q2 2021 and has held it in 2 quarters since. The position peaked at $2.12M in Q2 2021. 576 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

BBVA USA held 40,469 shares of Sanofi worth $1.95M as of Q3 2021.
BBVA USA bought 260 Sanofi shares in Q3 2021, an estimated $13.2K.
Sanofi made up 0.11% of BBVA USA's portfolio in Q3 2021, its #178 holding.
BBVA USA first reported a position in Sanofi in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Sanofi position peaked at $2.12M in Q2 2021.
576 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.